Home » Newsletters » BioWorld

BioWorld

April 5, 1994

View Archived Issues

CALGENE SEEKS USDA APPROVAL OF ITS CANOLA

T CELL SCIENCES, SMITHKLINE HALT CLINICAL TRIAL

AGRIDYNE HAS TWO PATENTS ALLOWED, GETS SBIR GRANT

JAPANESE FIRM LICENSES CHIRON RNA PROBE

LOOK-ALIKE AUTOIMMUNE ANTIBODIES BLOCK HIV

BIOTECHNOLOGY STOCK PERFORMANCE FOR FIRST QUARTER 1994

INTERNEURON'S STROKE DRUG BEGINS PHASE II/III TRIALS

ALKERMES BEGINS RMP-7 TRIALS

APPOINTMENTS AND ADVANCEMENTS

IMMUNEX FILES NEW SUPPLEMENTAL PLA FOR LEUKINE

TO OUR READERS

HEMOSOL FILES IND FOR RED BLOOD CELL SUBSTITUTE

NEORX'S INFRINGEMENT SUIT GOES ON

MAGAININ'S MSI-78 FOR IMPETIGO DEALT A SETBACK

TEACHING CELLS TO MAKE THEIR OWN ANTI-AIDS INTERFERON

GENEMEDICINE FILES FOR IPO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...